C. Zhu, A. Anderson, A. Schubart, H. Xiong, J. Imitola et al., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity, Nature Immunology, vol.190, issue.12, pp.1245-1252, 2005.
DOI : 10.1038/ni1271

S. Oomizu, T. Arikawa, T. Niki, T. Kadowaki, M. Ueno et al., Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner, Clinical Immunology, vol.143, issue.1, pp.51-58, 2012.
DOI : 10.1016/j.clim.2012.01.004

M. Seki, S. Oomizu, K. Sakata, A. Sakata, T. Arikawa et al., Galectin-9 suppresses the generation of http, p.16

P. Reddy, S. Sehrawat, A. Suryawanshi, N. Rajasagi, S. Mulik et al., Influence of Galectin-9/Tim-3 Interaction on Herpes Simplex Virus-1 Latency, The Journal of Immunology, vol.187, issue.11, pp.5745-5755, 2011.
DOI : 10.4049/jimmunol.1102105

S. Sehrawat, A. Suryawanshi, M. Hirashima, and B. Rouse, Role of Tim-3/Galectin-9 Inhibitory Interaction in Viral-Induced Immunopathology: Shifting the Balance toward Regulators, The Journal of Immunology, vol.182, issue.5, pp.3191-3201, 2009.
DOI : 10.4049/jimmunol.0803673

S. Sharma, A. Sundararajan, A. Suryawanshi, N. Kumar, T. Veiga-parga et al., T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses, Proceedings of the National Academy of Sciences, vol.108, issue.47, pp.19001-19006, 2011.
DOI : 10.1073/pnas.1107087108

K. Koguchi, D. Anderson, L. Yang, O. Connor, K. Kuchroo et al., Dysregulated T cell expression of TIM3 in multiple sclerosis, The Journal of Experimental Medicine, vol.147, issue.6, pp.1413-1418, 2006.
DOI : 10.1016/S0165-5728(98)00086-1

L. Yang, D. Anderson, J. Kuchroo, and D. Hafler, Lack of TIM-3 Immunoregulation in Multiple Sclerosis, The Journal of Immunology, vol.180, issue.7, pp.4409-4414, 2008.
DOI : 10.4049/jimmunol.180.7.4409

J. Lee, E. Park, J. Noh, J. Hwang, E. Bae et al., Underexpression of TIM-3 and Blunted Galectin-9-Induced Apoptosis of CD4+ T Cells in Rheumatoid Arthritis, Inflammation, vol.56, issue.2, pp.633-637, 2011.
DOI : 10.1007/s10753-011-9355-z

R. Liberal, C. Grant, B. Holder, Y. Ma, G. Mieli-vergani et al., The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway, Hepatology, vol.5, issue.2, 2012.
DOI : 10.1002/hep.25682

J. Klibi, T. Niki, A. Riedel, C. Pioche-durieu, S. Souquere et al., Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells, Blood, vol.113, issue.9, pp.1957-1966, 2009.
DOI : 10.1182/blood-2008-02-142596

J. Mengshol, L. Golden-mason, T. Arikawa, M. Smith, T. Niki et al., A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection, PLoS ONE, vol.5, issue.3, p.9504, 2010.
DOI : 10.1371/journal.pone.0009504.s002

M. Stancic, J. Van-horssen, V. Thijssen, H. Gabius, P. Van-der-valk et al., Increased expression of distinct galectins in multiple sclerosis lesions, Neuropathology and Applied Neurobiology, vol.55, issue.1, pp.654-671, 2011.
DOI : 10.1111/j.1365-2990.2011.01184.x

M. Seki, K. Sakata, S. Oomizu, T. Arikawa, A. Sakata et al., Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts, Arthritis & Rheumatism, vol.1572, issue.12, pp.3968-3976, 2007.
DOI : 10.1002/art.23076

T. Niki, S. Tsutsui, S. Hirose, S. Aradono, Y. Sugimoto et al., Galectin-9 Is a High Affinity IgE-binding Lectin with Anti-allergic Effect by Blocking IgE-Antigen Complex Formation, Journal of Biological Chemistry, vol.284, issue.47, pp.32344-32352, 2009.
DOI : 10.1074/jbc.M109.035196

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781649

N. Nishi, A. Abe, J. Iwaki, H. Yoshida, A. Itoh et al., Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1, Glycobiology, vol.18, issue.12, pp.1065-1073, 2008.
DOI : 10.1093/glycob/cwn089

N. Nishi, A. Itoh, A. Fujiyama, N. Yoshida, S. Araya et al., Development of highly stable galectins: Truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins, FEBS Letters, vol.21, issue.10, pp.2058-2064, 2005.
DOI : 10.1016/j.febslet.2005.02.054

M. Gleason, T. Lenvik, V. Mccullar, M. Felices, O. Brien et al., Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9, Blood, vol.2012, issue.13, pp.1193064-3072

L. Ndhlovu, S. Lopez-verges, J. Barbour, R. Jones, A. Jha et al., Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity, Blood, vol.119, issue.16, pp.1193734-3743
DOI : 10.1182/blood-2011-11-392951

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335380

C. Pioche-durieu, C. Keryer, S. Souquere, J. Bosq, W. Faigle et al., In Nasopharyngeal Carcinoma Cells, Epstein-Barr Virus LMP1 Interacts with Galectin 9 in Membrane Raft Elements Resistant to Simvastatin, nasopharyngeal carcinoma cells, pp.13326-13337, 2005.
DOI : 10.1128/JVI.79.21.13326-13337.2005

C. Louis, K. Straathof, C. Bollard, S. Ennamuri, C. Gerken et al., Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma, Journal of Immunotherapy, vol.33, issue.9, pp.983-990, 2010.
DOI : 10.1097/CJI.0b013e3181f3cbf4

C. Smith, J. Tsang, L. Beagley, D. Chua, V. Lee et al., Effective Treatment of Metastatic Forms of Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy, Cancer Research, vol.72, issue.5, pp.1116-1125, 2012.
DOI : 10.1158/0008-5472.CAN-11-3399